Literature DB >> 16085592

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

Ursula Nestle1, Stephanie Kremp, Andrea Schaefer-Schuler, Christiane Sebastian-Welsch, Dirk Hellwig, Christian Rübe, Carl-Martin Kirsch.   

Abstract

UNLABELLED: PET with (18)F-FDG ((18)F-FDG PET) is increasingly used in the definition of target volumes for radiotherapy, especially in patients with non-small cell lung cancer (NSCLC). In this context, the delineation of tumor contours is crucial and is currently done by different methods. This investigation compared the gross tumor volumes (GTVs) resulting from 4 methods used for this purpose in a set of clinical cases.
METHODS: Data on the primary tumors of 25 patients with NSCLC were analyzed. They had (18)F-FDG PET during initial tumor staging. Thereafter, additional PET of the thorax in treatment position was done, followed by planning CT. CT and PET images were coregistered, and the data were then transferred to the treatment planning system (PS). Sets of 4 GTVs were generated for each case by 4 methods: visually (GTV(vis)), applying a threshold of 40% of the maximum standardized uptake value (SUV(max); GTV(40)), and using an isocontour of SUV = 2.5 around the tumor (GTV(2.5)). By phantom measurements we determined an algorithm, which rendered the best fit comparing PET with CT volumes using tumor and background intensities at the PS. Using this method as the fourth approach, GTV(bg) was defined. A subset of the tumors was clearly delimitable by CT. Here, a GTV(CT) was determined.
RESULTS: We found substantial differences between the 4 methods of up to 41% of the GTV(vis). The differences correlated with SUV(max), tumor homogeneity, and lesion size. The volumes increased significantly from GTV(40) (mean 53.6 mL) < GTV(bg) (94.7 mL) < GTV(vis) (157.7 mL) and GTV(2.5) (164.6 mL). In inhomogeneous lesions, GTV(40) led to visually inadequate tumor coverage in 3 of 8 patients, whereas GTV(bg) led to intermediate, more satisfactory volumes. In contrast to all other GTVs, GTV(40) did not correlate with the GTV(CT).
CONCLUSION: The different techniques of tumor contour definition by (18)F-FDG PET in radiotherapy planning lead to substantially different volumes, especially in patients with inhomogeneous tumors. Here, the GTV(40) does not appear to be suitable for target volume delineation. More complex methods, such as system-specific contrast-oriented algorithms for contour definition, should be further evaluated with special respect to patient data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085592

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  184 in total

1.  Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy.

Authors:  Tony Shepherd; Mika Teras; Reinhard R Beichel; Ronald Boellaard; Michel Bruynooghe; Volker Dicken; Mark J Gooding; Peter J Julyan; John A Lee; Sébastien Lefèvre; Michael Mix; Valery Naranjo; Xiaodong Wu; Habib Zaidi; Ziming Zeng; Heikki Minn
Journal:  IEEE Trans Med Imaging       Date:  2012-06-04       Impact factor: 10.048

2.  FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position.

Authors:  Irene A Burger; David A Scheiner; David W Crook; Valerie Treyer; Thomas F Hany; Gustav K von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-21       Impact factor: 9.236

3.  Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET.

Authors:  Lieselot Brepoels; Marijke De Saint-Hubert; Sigrid Stroobants; Gregor Verhoef; Jan Balzarini; Luc Mortelmans; Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-12       Impact factor: 9.236

Review 4.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques.

Authors:  Habib Zaidi; Issam El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-25       Impact factor: 9.236

5.  Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice.

Authors:  Carmelo Quarta; Erika Cantelli; Cristina Nanni; Valentina Ambrosini; Daniela D'ambrosio; Korinne Di Leo; Silvia Angelucci; Federico Zagni; Filippo Lodi; Mario Marengo; William A Weiss; Andrea Pession; Roberto Tonelli; Stefano Fanti
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

Review 6.  Functional MRI for radiotherapy dose painting.

Authors:  Uulke A van der Heide; Antonetta C Houweling; Greetje Groenendaal; Regina G H Beets-Tan; Philippe Lambin
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

Review 7.  Magnetic resonance imaging in lung: a review of its potential for radiotherapy.

Authors:  Shivani Kumar; Gary Liney; Robba Rai; Lois Holloway; Daniel Moses; Shalini K Vinod
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

8.  Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.

Authors:  M Picchio; M Kirienko; P Mapelli; I Dell'Oca; E Villa; F Gallivanone; L Gianolli; C Messa; I Castiglioni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-29       Impact factor: 9.236

Review 9.  Machine learning in quantitative PET: A review of attenuation correction and low-count image reconstruction methods.

Authors:  Tonghe Wang; Yang Lei; Yabo Fu; Walter J Curran; Tian Liu; Jonathon A Nye; Xiaofeng Yang
Journal:  Phys Med       Date:  2020-07-29       Impact factor: 2.685

10.  Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma.

Authors:  Salim Kanoun; Cédric Rossi; Alina Berriolo-Riedinger; Inna Dygai-Cochet; Alexandre Cochet; Olivier Humbert; Michel Toubeau; Emmanuelle Ferrant; François Brunotte; René-Olivier Casasnovas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.